For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.
The purpose of this rep...ort is to provide forecasts of future demand for medicines used in the fields of HIV, viral hepatitis and STIs. This report jointly presents medicines forecasts across three disease areas in recognition of the benefits of addressing HIV, viral hepatitis and STIs in a coordinated manner.
more
National Tuberclosis and
Leprosy Programme (NTLP)
World Aids Day, 1. December 2018
Commemorating 30 Years
Accessed: 05.10.2019
Antimicrobial Resistance and Infection Control 2014,3 :31
Cards for Correct and Incorrect Components of Evidence-based Focused ANC (including birth preparedness, complication readiness and recognition of danger signs)
HIV treatment
Policy brief
July 2017
WHO/HIV/2017.18
Dziva Chikwari et al. Implementation Science (2018) 13:70 https://doi.org/10.1186/s13012-018-0762-5
Evaluation report
September 2014
Technical Brief
HIV patient monitoring and case surveillance
WHO/HIV/2017.12
HIV & AIDS Treatment in Practice No.202